Latest News & Technotes
We will have a booth at Alzheimer’s Association International Conference (AAIC) 2022 in San Diego July 30 to August 3. We hope to see you there!
We will be at FENS 2022 in Paris July 9-13th. Please join us! Xona sells devices worldwide, including the United Kingdom, Germany, France, Italy, and the rest of Europe.
How are XonaChips different from our Silicone Devices? In this Tech Note, we discuss the advantages of each type of compartmentalized microfluidic chamber so that you can decided which configuration is best for your application.
Xona sells devices worldwide, including the United Kingdom, Germany, France, Italy, and the rest of Europe. We will be at FENS 2022 in Paris July 9-13th. Please join us!
Customize Neuronal Microenvironments with
Xona Microfluidic Devices
Xona Microfluidics® provides high quality microfluidic devices for compartmentalizing neurons.
Our expert team includes neuroscientists with critical experience designing and conducting research. Xona has been awarded numerous NIH grants and, in 2020, began offering contract research services.
Xona holds the original, exclusive license to sell compartmentalized microfluidic devices, originally described in Nature Methods (2005). Dr. Anne Taylor, an inventor, is Xona’s Chief Scientific Officer.
Our microfluidic devices enable the unique study of neuronal subcellular compartments and lead to the development of valuable in vitro models of the NMJ and other co-culture innervation models. Our devices are used extensively for Alzheimer’s disease, ALS, and Parkinson’s disease research.
Xona’s time-tested technology has been cited in over 1,000 publications. Many of these publications can be found on our publications page.
Both primary neurons and human iPSC-derived neurons can be easily cultured within our platforms. Neurons can be cultured for 21 or more days. Xona Microfluidics® sells both the original Silicone (PDMS) Devices as well as our newer XonaChips® which are made of optically transparent cyclic olefin copolymer.